Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 5:01 PM View:  | Crinetics Pharmaceuticals, ... (CRNX) | 26-Sep-24 | Option Exercise | 25,000 | $15.29 | $382,250.00 | 23% 111.09K to 136.09K | |
| 30-Sep-24 5:01 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 26-Sep-24 | Planned Option Sale | 25,000 | $51.11 | $1,277,750.00 | (18%) 136.09K to 111.09K | |
| 26-Jul-24 4:24 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jul-24 | Option Exercise | 19,056 | $9.28 | $176,840.00 | 17% 111.09K to 130.15K | |
| 26-Jul-24 4:24 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jul-24 | Planned Option Sale | 19,056 | $53.88 | $1,026,740.00 | (15%) 130.15K to 111.09K | |
| 17-Jul-24 5:14 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Option Exercise | 25,000 | $20.02 | $500,500.00 | 23% 111.09K to 136.09K | |
| 17-Jul-24 5:14 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Planned Option Sale | 25,000 | $55.00 | $1,375,000.00 | (18%) 136.09K to 111.09K | |
| 20-Mar-24 6:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 19-Mar-24 | Sale (Planned) | 6,942 | $42.91 | $297,881.00 | (6%) 117.57K to 110.63K | |
| 20-Mar-24 6:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 3,983 | $38.14 | $151,912.00 | (3%) 121.56K to 117.57K | |
| 06-Mar-24 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 25,500 | -- | -- | 27% 96.06K to 121.56K | |
| 04-Jan-24 4:43 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 02-Jan-24 | Option Exercise | 10,000 | $9.28 | $92,800.00 | 10% 96.06K to 106.06K | |
| 04-Jan-24 4:43 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 02-Jan-24 | Planned Option Sale | 10,000 | $35.47 | $354,700.00 | (9%) 106.06K to 96.06K | |
| 03-Nov-23 7:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-23 | Option Exercise | 10,000 | $9.28 | $92,800.00 | 10% 95.6K to 105.6K | |
| 03-Nov-23 7:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-23 | Option Sale | 10,000 | $28.75 | $287,500.00 | (9%) 105.6K to 95.6K | |
| 21-Jun-23 5:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Jun-23 | Option Exercise | 20,000 | $9.28 | $185,600.00 | 19% 106.08K to 126.08K | |
| 21-Jun-23 5:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Jun-23 | Option Sale | 20,000 | $19.97 | $399,329.00 | (16%) 126.08K to 106.08K | |
| 21-Jun-23 5:32 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Jun-23 | Sale | 10,922 | $19.97 | $218,074.00 | (10%) 106.08K to 95.16K | |
| 17-Mar-23 5:11 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Mar-23 | Payment of Exercise | 1,666 | $17.12 | $28,521.90 | (2%) 107.75K to 106.08K | |
| 03-Mar-23 4:33 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-23 | Grant | 24,200 | -- | -- | 29% 83.55K to 107.75K | |
| 27-Jan-23 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-22 | Acquisition (other) | 482 | $11.02 | $5,311.64 | < 1% 83.06K to 83.55K | |
| 27-Jan-23 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-22 | Acquisition (other) | 1,446 | $11.02 | $15,934.90 | 2% 81.62K to 83.06K | |
| 02-Mar-22 9:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 28-Feb-22 | Grant | 19,500 | -- | -- | 31% 62.12K to 81.62K | |
| 04-Feb-22 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 19-Nov-21 | Acquisition (other) | 837 | $11.02 | $9,223.74 | 1% 61.28K to 62.12K | |
| 04-Feb-22 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-21 | Acquisition (other) | 1,090 | $11.02 | $12,011.80 | 2% 60.19K to 61.28K | |
| 05-Feb-21 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-20 | Acquisition (other) | 702 | $11.61 | $8,150.22 | 1% 59.49K to 60.19K | |
| 05-Feb-21 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-20 | Acquisition (other) | 697 | $14.45 | $10,071.60 | 1% 58.79K to 59.49K | |
| 11-Feb-20 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-May-19 | Acquisition (other) | 1,471 | $14.45 | $21,255.90 | 3% 57.32K to 58.79K | |
| 12-Feb-19 10:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-18 | Acquisition (other) | 1,470 | $14.45 | $21,241.50 | 3% 55.85K to 57.32K | |
| 19-Sep-17 4:44 PM View: | Cidara Therapeutics, Inc. (CDTX) | 18-Sep-17 | Grant | 5,000 | -- | -- | 93% 5.36K to 10.36K |